Home/Spyre Therapeutics/Heidy King-Jones
HK

Heidy King-Jones

Chief Legal Officer and Corporate Secretary

Spyre Therapeutics

Spyre Therapeutics Pipeline

DrugIndicationPhase
SPY001Ulcerative Colitis (UC)Phase 2
SPY002Ulcerative Colitis (UC)Phase 2
SPY003Ulcerative Colitis (UC)Phase 2
SPY120Ulcerative Colitis (UC)Phase 1
SPY130Ulcerative Colitis (UC)Phase 1
SPY230Ulcerative Colitis (UC)Phase 1
SPY072Rheumatoid Arthritis (RA)Phase 2